Research Supports FDA Label Update for Echocardiogram Agent

Neil Weissman, MD, commented on the U.S. Food and Drug Administration (FDA) approval of an important label update for an echocardiogram contrast agent. “This is particularly noteworthy as DEFINITY is the most widely used echocardiography agent in the U.S. with published data supporting its safety profile across multiple care settings,” said Dr. Weissman. Read more.